Who owns CGWhat CG owns
What Carlyle Group Inc. owns
The company's own 13F portfolio · as of 2026-06-30 · long US-listed stakes only — private holdings, bonds and cash are not disclosable on a 13F
$10.00B
disclosed stock portfolio
19
positions
73.8%
in MDLN
Positions, as of 2026-06-30
ordered by filed value · % of book = share of the disclosed stock portfolio · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | MDLNMedline Inc | 187.1M | $7.38B | 73.8% |
| 2 | SAROStandardaero Inc | 84.6M | $2.53B | 25.3% |
| 3 | PHATPhathom Pharmaceuticals Inc | 3.5M | $37.9M | 0.4% |
| 4 | INVHInvitation Homes Inc | 662,900 | $20.0M | 0.2% |
| 5 | PONYPony Ai Inc | 2.4M | $16.4M | 0.2% |
| 6 | GETYGetty Images Holdings Inc | 6.2M | $5.4M | 0.1% |
| 7 | SPRBSpruce Biosciences Inc | 38,620 | $2.1M | 0% |
| 8 | SPWRSunPower Inc | 2.3M | $1.6M | 0% |
| 9 | ACETAdicet Bio Inc | 184,295 | $1.6M | 0% |
| 10 | FWRDForward Air Corp | 107,214 | $1.4M | 0% |
| 11 | OKUROnkure Therapeutics Inc | 269,895 | $1.2M | 0% |
| 12 | DNUTKrispy Kreme Inc | 340,748 | $1.2M | 0% |
| 13 | QTTBQ32 Bio Inc | 60,363 | $769,020 | 0% |
| 14 | REPXRiley Exploration Permian In | 16,092 | $530,387 | 0% |
| 15 | NBISNebius Group N.V. | 1,846 | $509,810 | 0% |
| 16 | HOODRobinhood Mkts Inc | 4,733 | $474,625 | 0% |
| 17 | JSPRJasper Therapeutics Inc | 1.1M | $448,866 | 0% |
| 18 | NABLN-able Inc | 93,732 | $343,996 | 0% |
| 19 | METCRamaco Res Inc | 21,743 | $287,667 | 0% |
Source: SEC Form 13F-HR filed by Carlyle Group Inc. (CIK 1527166), reporting period 2026-06-30. Values are quarter-end filed marks. Research, not investment advice.